Wisdom Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IBRUTINIB, with a corresponding US DMF Number 31917.
Remarkably, this DMF maintains an Active status since its submission on July 20, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 22, 2025, and payment made on July 21, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II